Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
65.18
+0.40 (0.62%)
At close: Apr 2, 2026, 4:00 PM EDT
64.00
-1.18 (-1.81%)
After-hours: Apr 2, 2026, 4:25 PM EDT
Disc Medicine Stock Forecast
Stock Price Forecast
The 11 analysts that cover Disc Medicine stock have a consensus rating of "Strong Buy" and an average price target of $103.18, which forecasts a 58.30% increase in the stock price over the next year. The lowest target is $79 and the highest is $125.
Price Target: $103.18 (+58.30%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 2, 2026.
Analyst Ratings
The average analyst rating for Disc Medicine stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 5 | 5 | 5 |
| Buy | 6 | 7 | 7 | 8 | 8 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 13 | 13 | 13 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $78 → $79 | Buy | Maintains | $78 → $79 | +21.20% | Mar 2, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $114 → $83 | Strong Buy | Maintains | $114 → $83 | +27.34% | Feb 27, 2026 |
| Stifel | Stifel | Strong Buy Maintains $125 → $110 | Strong Buy | Maintains | $125 → $110 | +68.76% | Feb 17, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $153 → $125 | Buy | Maintains | $153 → $125 | +91.78% | Feb 17, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $120 → $100 | Buy | Maintains | $120 → $100 | +53.42% | Feb 17, 2026 |
Financial Forecast
Revenue This Year
7.20M
Revenue Next Year
27.62M
from 7.20M
Increased by 283.52%
EPS This Year
-7.24
from -6.01
EPS Next Year
-7.67
from -7.24
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 74.1M | 56.5M | |||
| Avg | 7.2M | 27.6M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 684.3% | |||
| Avg | - | 283.5% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -6.72 | -6.14 | |||
| Avg | -7.24 | -7.67 | |||
| Low | -8.38 | -9.19 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.